BARCLAYS PLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 46 filers reported holding PROQR THRAPEUTICS N V in Q2 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2022$20,00022,600
+56400.0%
0.00%
Q4 2021$040
+73.9%
0.00%
Q3 2021$023
-34.3%
0.00%
Q2 2021$0350.0%0.00%
Q1 2021$0
-100.0%
35
-98.9%
0.00%
Q4 2020$13,000
-69.8%
3,188
-64.5%
0.00%
Q3 2020$43,000
-32.8%
8,988
-14.3%
0.00%
Q2 2020$64,000
+255.6%
10,488
+212.8%
0.00%
Q1 2020$18,000
+350.0%
3,353
+858.0%
0.00%
Q4 2019$4,000
-66.7%
350
-84.7%
0.00%
Q3 2019$12,000
-33.3%
2,287
+9.8%
0.00%
Q2 2019$18,000
-92.6%
2,083
-88.1%
0.00%
Q1 2019$243,000
+376.5%
17,453
+442.7%
0.00%
Q4 2018$51,0003,2160.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 748,861$6,815,0002.37%
Opus Point Partners Management, LLC 138,461$1,260,0001.86%
RTW INVESTMENTS, LP 3,722,950$33,879,0001.81%
Kerrisdale Advisers, LLC 465,580$4,237,0001.52%
DAFNA Capital Management LLC 261,521$2,380,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 470,000$4,277,0000.58%
Artal Group S.A. 1,300,000$11,830,0000.48%
Orbimed Advisors 1,382,502$12,581,0000.20%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,000$511,0000.19%
ALTRINSIC GLOBAL ADVISORS LLC 201,360$1,832,0000.08%
View complete list of PROQR THRAPEUTICS N V shareholders